ChiCTR2300075546 版本V1.1 版本创建时间2024/02/04 21:20:33 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300075546 

最近更新日期:

Date of Last Refreshed on:

2023-09-08 08:33:17 

注册时间:

Date of Registration:

2023-09-08 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

利多卡因复合罗哌卡因用于分娩镇痛改善产时发热的研究

Public title:

The effect of adding Lidocaine to epidural Ropivacaine on the Maternal Related Epidural fever for labor epidural analgesia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

利多卡因复合罗哌卡因用于分娩镇痛改善产时发热的研究

Scientific title:

The effect of adding Lidocaine toepidural Ropivacaine on the Maternal Related Epidural fever for labor epidural analgesia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

肖飞 

研究负责人:

沈蓓 

Applicant:

Xiao Fei 

Study leader:

Shen Bei 

申请注册联系人电话:

Applicant telephone:

+86 137 0659 7501

研究负责人电话:

Study leader's telephone:

+86 152 5732 3291

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

13706597501@163.com

研究负责人电子邮件:

Study leader's E-mail:

sbjane@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国浙江省嘉兴市中环东路2468号

研究负责人通讯地址:

中国浙江省嘉兴市中环东路2468号

Applicant address:

NO. 2468, East Zhonghuang Road

Study leader's address:

NO. 2468, East Zhonghuang Road

申请注册联系人邮政编码:

Applicant postcode:

314000

研究负责人邮政编码:

Study leader's postcode:

314000

申请人所在单位:

嘉兴市妇幼保健院

Applicant's institution:

Jiaxing Metemal and Child Health Hospital

研究负责人所在单位:

嘉兴市妇幼保健院

Affiliation of the Leader:

Jiaxing Metemal and Child Health Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

嘉妇保伦审2022研第187号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

嘉兴市妇幼保健院伦理委员会

Name of the ethic committee:

Ethics Committee of Jiaxing Metemal and Child Health Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-07 00:00:00

伦理委员会联系人:

王瑜

Contact Name of the ethic committee:

Wang Yu

伦理委员会联系地址:

浙江省嘉兴市中环东路2468号

Contact Address of the ethic committee:

2468 Zhonghuan Road East,Jiaxing,Zhejiang

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 573 8396 6700

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

嘉兴学院附属妇女儿童医院

Primary sponsor:

Jiaxing University Affiliated Women and Children Hospital

研究实施负责(组长)单位地址:

浙江省嘉兴市中环东路2468号

Primary sponsor's address:

2468 Zhonghuan Road East,Jiaxing,Zhejiang

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江

市(区县):

嘉兴

Country:

China

Province:

Zhejiang

City:

Jiaxing

单位(医院):

嘉兴学院附属妇女儿童医院

具体地址:

中环东路2468号

Institution
hospital:

Jiaxing University Affiliated Women and Children Hospital

Address:

2468 Zhonghuan Road East

经费或物资来源:

医院支持

Source(s) of funding:

supported by hospital

Target disease:

Epidural block labor fever

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.观察利多卡因复合罗哌卡因与单用罗哌卡因对产妇产时发热率的比较 2.观察两组出现产时发热的时间、WBC、胎盘病检感染率、抗生素使用率 3.产时发热结局比较:顺转剖率;器械助产率;新生儿出生状况、产程时长。  

Objectives of Study:

1. To observe the effect of lidocaine combined with ropivacaine and ropivacaine alone on maternal fever rate during childbirth 2. The time of intrapartum fever, WBC, infection rate of placental disease and antibiotic use rate of the two groups were observed 3. Comparison of parturient fever outcomes: anterograde profile rate; Instrumental midwifery rate; Neonatal birth status and duration of labor.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

足月、头位、单胎初产妇,ASA Ⅱ级、宫口开至2~5cm,要求行分娩镇痛,实施无痛分娩前产妇的WBC、HB正常,体温(耳温枪)正常

Inclusion criteria

There was no statistical significance in the comparison of age, weight, height and BMI between the two groups. The uterine orifice was opened to 2~3cmLabor analgesia, ASAⅠ-Ⅱ grade, full term, cephalic, single primiparas selected. Maternal WBC before painless delivery,HB is normal, body temperature (ear temperature gun) is normal.

排除标准:

排除感染性疾病、胎膜早破和患有内科疾病的产妇如妊娠期高血症、妊娠期糖尿病、妊娠期甲状腺疾病等。

Exclusion criteria:

Women with infectious diseases, premature rupture of membranes and medical conditions, such as hyperemia during pregnancy, gestational diabetes, thyroid disease during pregnancy, were excluded

研究实施时间:

Study execute time:

From 2023-09-10 00:00:00 To 2024-07-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-09-10 00:00:00 To 2024-07-30 00:00:00  

干预措施:

Interventions:

组别:

A组

样本量:

200

Group:

groupA

Sample size:

干预措施:

0.5%利多卡因复合0.075%罗哌卡因

干预措施代码:

Intervention:

0.5% lidocaine with 0.075% ropivacaine

Intervention code:

组别:

B组

样本量:

200

Group:

groupB

Sample size:

干预措施:

0.075%罗哌卡因

干预措施代码:

Intervention:

0.075% ropivacaine

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

嘉兴 

Country:

China 

Province:

Zhejiang 

City:

Jiaxing 

单位(医院):

嘉兴市妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

Jiaxing Metemal and Child Health Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

体温

指标类型:

主要指标

Outcome:

Body temperature

Type:

Primary indicator

测量时间点:

无痛分娩后每个1小时

测量方法:

耳温枪

Measure time point of outcome:

Each 1 h after painless delivery

Measure method:

Ear temperature gun

指标中文名:

副作用

指标类型:

次要指标

Outcome:

side effects

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视觉模拟疼痛评分

指标类型:

次要指标

Outcome:

Visual analogue scale for pain

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体温>38.5比例

指标类型:

主要指标

Outcome:

Proportion of body temperature>38.5

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

胎儿评分及血气分析结果

指标类型:

次要指标

Outcome:

Fetal score and blood gas analysis results

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

分娩方式

指标类型:

次要指标

Outcome:

Delivery method

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

指标类型:

主要指标

Outcome:

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Null

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

随机数表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random digital tables

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

硬膜外药物由清楚分组情况的护士进行统一配置,但是其不参加患者镇痛管理及数据收集。

Blinding:

The epidural study solution was prepared by a fixed nurse who was aware of the patient grouping but did not be involved in pain management and data collection.

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

本网站

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

on thisweb

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

上传统计数据

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

upload the statistic data

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-09-08 08:32:49